{"altmetric_id":3268712,"counts":{"readers":{"mendeley":0,"citeulike":0,"connotea":0},"total":{"posts_count":1},"wikipedia":{"unique_users_count":1,"unique_users":["en:837167"],"posts_count":1}},"citation":{"abstract":"The incidence of secondary leukemia after epipodophyllotoxin treatment and the relationship between epipodophyllotoxin cumulative dose and risk are not well characterized. The Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute (NCI) has developed a monitoring plan to obtain reliable estimates of the risk of secondary leukemia after epipodophyllotoxin treatment.","abstract_source":"pubmed","altmetric_jid":"4f6fa5e93cf058f610005a18","authors":["M A Smith","L Rubinstein","J R Anderson","D Arthur","P J Catalano","B Freidlin","R Heyn","A Khayat","M Krailo","V J Land","J Miser","J Shuster","D Vena"],"doi":"10.1200\/jco.1999.17.2.569","first_seen_on":"2015-02-03T15:58:04+00:00","handles":[],"isbns":[],"issns":["0732-183X"],"issue":"2","journal":"Journal of Clinical Oncology","last_mentioned_on":1238102830,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10080601"],"pmid":"10080601","pubdate":"1999-02-01T00:00:00+00:00","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"subjects":["neoplasms"],"title":"Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins.","type":"article","volume":"17","mendeley_url":"http:\/\/www.mendeley.com\/research\/secondary-leukemia-myelodysplastic-syndrome-after-treatment-epipodophyllotoxins-2"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":3627464,"mean":4.9483847763613,"rank":817640,"this_scored_higher_than_pct":63,"this_scored_higher_than":2286496,"rank_type":"exact","sample_size":3627464,"percentile":63},"similar_age_3m":{"total_number_of_other_articles":93906,"mean":8.0091878174752,"rank":24290,"this_scored_higher_than_pct":72,"this_scored_higher_than":68530,"rank_type":"exact","sample_size":93906,"percentile":72},"this_journal":{"total_number_of_other_articles":4898,"mean":8.1983259138248,"rank":2072,"this_scored_higher_than_pct":50,"this_scored_higher_than":2454,"rank_type":"exact","sample_size":4898,"percentile":50},"similar_age_this_journal_3m":{"total_number_of_other_articles":88,"mean":12.358022988506,"rank":54,"this_scored_higher_than_pct":37,"this_scored_higher_than":33,"rank_type":"exact","sample_size":88,"percentile":37}}},"demographics":{"users":{"mendeley":{"by_status":{"Student  > Doctoral Student":2,"Researcher":1,"Student  > Master":1},"by_discipline":{"Medicine and Dentistry":4}}}},"posts":{"wikipedia":[{"title":"Acute lymphoblastic leukemia","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=279878642#altmetric_citation_9","license":"public","citation_ids":[3268712],"posted_on":"2009-03-26T21:27:10+00:00","summary":"Acute lymphoblastic leukemia (ALL) or acute lymphoid leukemia is an acute form of leukemia, or cancer of the white blood cells, characterized by the overproduction of cancerous, immature white blood cells\u2014known as lymphoblasts.","page_url":"http:\/\/en.wikipedia.org\/?curid=837167","wiki_lang":"en","author":{"name":"Shadowjams","url":"http:\/\/en.wikipedia.org\/wiki\/User:Shadowjams"}}]}}